{"disease":{"id":"moderate-to-severe-allergic-asthma","name":"moderate to severe allergic asthma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06348407","title":"A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT04195958","title":"A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Genentech, Inc.","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}